Under the proposed changes, there would be an overall negative reimbursement for the category of items, services and procedures under the Medicare Inpatient Prospective Payment System.
Citing an “overly stringent criteria for new-technology add-on payments,” MDMA said some devices might not meet the cost threshold under the proposal.
Read the MDMA release on medical device payments.
Read the full MDMA comments to CMS (pdf).
Related Articles on the Medical Device Manufacturers Association:
MDMA: GPOs Should Be Included in “Sunshine” Provisions
MDMA Announces Support of Legislation to Strengthen the Research & Development Tax Credit
MDMA Applauds Bills to Repeal Medical Device Tax
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
